Kate Childs

Denmark Hill
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy.

Virological outcomes with Bictegravir/Emtricitabine/Tenofovir alafenamide (B/F/TAF) in people previously treated with darunavir-based antiretroviral therapy.

Journal: HIV medicine

Published: November 28, 2025

Supporting long-term engagement in HIV clinical care: Learning from the COVID-19 pandemic.

Supporting long-term engagement in HIV clinical care: Learning from the COVID-19 pandemic.

Journal: HIV medicine

Published: June 05, 2025

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study.

Switching Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide Fumarate (TAF) in Hepatitis B/HIV Co-Infection: A Feasibility Study.

Journal: Clinical therapeutics

Published: September 13, 2023

Reaching zero: Retention in HIV care is critical.

Reaching zero: Retention in HIV care is critical.

Journal: HIV medicine

Published: July 13, 2023

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.

Prevalence of HIV/hepatitis B and HIV/hepatitis C coinfection among people of East, South, Central and West African ancestry in the United Kingdom.

Journal: AIDS (London, England)

Published: April 30, 2021

Micro-elimination of HIV and HCV co-infection.

Micro-elimination of HIV and HCV co-infection.

Journal: The lancet. HIV

Published: October 30, 2020

Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series.

Hospitalized Patients With COVID-19 and Human Immunodeficiency Virus: A Case Series.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: May 28, 2020

On the impact of hepatitis C virus and heterologous immunity on alloimmune responses following liver transplantation.

On the impact of hepatitis C virus and heterologous immunity on alloimmune responses following liver transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: January 18, 2020

Reply to: "Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action".

Reply to: "Is resistance to direct-acting antivirals in sub-Saharan Africa a threat to HCV elimination? Recommendations for action".

Journal: Journal of hepatology

Published: November 17, 2019

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C.

Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C.

Journal: Journal of hepatology

Published: May 03, 2019

Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults.

Efficacy and Tolerability of Direct-Acting Antivirals for Hepatitis C in Older Adults.

Journal: Journal of the American Geriatrics Society

Published: May 26, 2018

Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: a case report and review of literature.

Dolutegravir-induced liver injury leading to sub-acute liver failure requiring transplantation: a case report and review of literature.

Journal: International journal of STD & AIDS

Published: October 24, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026